wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q41663868-3FE9E7B8-0532-470E-B5D9-AC792B44C3E9
Q41663868-3FE9E7B8-0532-470E-B5D9-AC792B44C3E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41663868-3FE9E7B8-0532-470E-B5D9-AC792B44C3E9
Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.
P2860
Q41663868-3FE9E7B8-0532-470E-B5D9-AC792B44C3E9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41663868-3FE9E7B8-0532-470E-B5D9-AC792B44C3E9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b0ec41ec14ec08d613dcf21ecff2842936f7748c
P2860
Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantat